Intravenous ketamine or esketamine given at the time of cesarean delivery reduced risk for postpartum depression; predictive models are needed to determine which women are most likely to benefit from this intervention.
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
A history of maternal psychiatric illness has been linked to postpartum depression (PPD), but this does not account for all instances of postpartum psychiatric illness. A recent study examined the impact of medical complications during [...]
We know that about 15% of women suffer from postpartum depression (PPD). But what is less clear is how to reliably identify women with PPD and to then ensure that they get the support and [...]
Most studies observe that about 15% of women experience postpartum depression (PPD). For the majority of women who present with postpartum depression, the postpartum episode is not the first ever episode of depression and instead [...]
